drugset / Trial / NCT01815515

Evaluation of 18F-DCFBC PSMA-based PET Imaging for Detection of Metastatic Prostate Cancer

NCT01815515 ↗

NaSingle-groupOpen-labelDiagnostic

Summary

This research is being done to see if an investigational radioactive drug called 18F-DCFBC can help us find cancer that has spread (metastatic disease) from its original site in people who have cancer in their prostate to other parts of their body.

Timeline

Start
2013-03
Primary completion
2015-07
Completion
2015-11-18

Drugs

EvaluationDrugModalityDoseRoute
Subject 18F-DCFBC Diagnostic / imaging agent 10 mbq Intravenous